First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (H...
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
About this item
Full title
Author / Creator
Matheron, Sophie , Descamps, Diane , Gallien, Sebastien , Besseghir, Amel , Sellier, Pierre , Blum, Laurent , Mortier, Emmanuel , Charpentier, Charlotte , Tubiana, Roland , Damond, Florence , Peytavin, Gilles , Ponscarme, Diane , Collin, Fideline , Brun-Vezinet, Francoise , Chene, Genevieve and France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
First-line raltegravir-containing combination antiretroviral therapy in 30 patients living with HIV-2 was well tolerated and yielded a median CD4 gain at 1 year of 87 cells/µL, and HIV-2 RNA <5 copies/µL in 13 of 15 participants.
Abstract
Background
New options for first-line treatment of human immunodeficiency virus type 2 (HIV-2) infecti...
Alternative Titles
Full title
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
Authors, Artists and Contributors
Author / Creator
Descamps, Diane
Gallien, Sebastien
Besseghir, Amel
Sellier, Pierre
Blum, Laurent
Mortier, Emmanuel
Charpentier, Charlotte
Tubiana, Roland
Damond, Florence
Peytavin, Gilles
Ponscarme, Diane
Collin, Fideline
Brun-Vezinet, Francoise
Chene, Genevieve
France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6160602
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6160602
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1093/cid/ciy245
